Sex differences in plasma prolactin response to tryptophan in chronic fatigue syndrome patients with and without comorbid fibromyalgia

Journal of Women's Health

Volumn 19, Issue 5, 2010, Pages 951-958

  Weaver, Shelley A ^a   Janal, Malvin N ^a   Aktan, Nadine ^a   Ottenweller, John E ^a   Natelson, Benjamin H ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KYNURENINE; PROLACTIN; TRYPTOPHAN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HUMAN; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; UPREGULATION;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CASE-CONTROL STUDIES; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; SEX CHARACTERISTICS; TRYPTOPHAN;

EID: 77952368734     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1697     Document Type: Article

References (46)

1. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006;367:346-355.
2. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-959.
3. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172.
4. Ciccone DS, Natelson BH. Comorbid illness in the chronic fatigue syndrome: A test of the single syndrome hypothesis. Psychosom Med 2003;62:268-275.
5. Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med 1999;130:910-921.
6. Parker AJR, Wessely S, Cleare AJ. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 2001;31:1331-1345. (Pubitemid 33040358)
7. Fernstrom JD, Fernstrom MH. Exercise, serum free tryptophan, and central fatigue. J Nutr 2006;136:553S-559S.
8. Davis JM, Alderson NL, Welsh RS. Serotonin and central nervous system fatigue: Nutritional considerations. Am J Clin Nutr 2000;72(Suppl 2):573S-578S.
9. Blomstrand E. Amino acids and central fatigue. Amino Acids 2001;20:25-34.
10. Yoshimura M, Furue H. Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J Pharmacol Sci 2006;101:107-117.
11. Messing RB, Fisher LA, Phebus L, Lytle LD. Interaction of diet and drugs in the regulation of brain 5-hydroxyindoles and the response to painful electric shock. Life Sci 1976;18: 707-714.
12. Lopez-Garcia JA. Serotonergic modulation of spinal sensory circuits. Curr Top Med Chem 2006;6:1987-1996.
13. Bakheit AMO, Behan PO, Dinan TG, Gray CE, O'Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ 1992;304:1010-1012.
14. Cleare AJ, Bearn J, Allain T, et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affective Disord 1995;34:283-289.
15. Sharpe M, Hawton K, Clements A, Cowen PJ. Increased brain serotonin function in men with chronic fatigue syndrome. BMJ 1997;315:164-165.
16. Sharpe M, Clements A, Hawton K, et al. Increased prolactin response to buspirone in chronic fatigue syndrome. J Affective Disord 1996;41:71-76.
17. Yatham LN, Morehouse RL, Chisholm BT, et al. Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome. Can J Psychiatry 1995;40: 93-96.
18. 2c receptor sensitivity in chronic fatigue syndrome. Psychol Med 2001;31: 585-591.
19. Bearn J, Allain T, Coskeran P, et al. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol Psychiatry 1995;37: 245-252.
20. 2 receptor function in fibromyalgia patients: A neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. J Affective Disord 2003;75:77-82.
21. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC. Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study. J Rheumatol 1992;19:90-94.
22. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Wall K. Serum amino acids in fibrositis=fibromyalgia syndrome. J Rheumatol (Suppl) 1989;19:158-163.
23. Moldofsky H, Warsh JJ. Plasma tryptophan and musculo-skeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain 1978;5:65-71.
24. Moir AT, Eccleston D. The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J Neurochem 1968; 15:1093-1108.
25. Gillman PK, Bartlett JR, Bridges PK, et al. Indolic substances in plasma, cerebrospinal fluid, and frontal cortex of human subjects infused with saline or tryptophan. J Neurochem 1981;37:410-417.
26. van der Stelt HM, Broersen LM, Olivier B, Westenberg HG. Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology (Berl) 2004;172:137-144.
27. Fernstrom JD. Effects of the diet and other metabolic phenomena on brain tryptophan uptake and serotonin synthesis. Adv Exp Med Biol 1991;294:369-376.
28. Marcus S, Robins LN, Bucholz K. Quick Diagnostic Interview Schedule 3R, version 1. St. Louis, MO: Washington University School of Medicine, 1990.
29. Natelson BH, Johnson SK, DeLuca J, et al. Reducing heterogeneity in chronic fatigue syndrome: A comparison with depression and multiple sclerosis. Clin Infect Dis 1995;21: 1204-1210.
30. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997;43:2424-2426.
31. Laich A, Neurauter G, Widner B, Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 2002;48:579-581.
32. Thayer RE. The activation-deactivation adjective check list (AD ACL). The biopsychology of mood and arousal. New York: Oxford University Press, 1989: 178-180.
33. Jason LA, Richman JA, Rademaker AW, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999;159:2129-2137.
34. Riblet LA, Taylor DP, Eison MS, Stanton HC. Pharmacology and neurochemistry of buspirone. J Clin Psychiatry 1982;43: 11-18.
35. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia=fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35: 550-556.
36. 3H]-imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxf) 2001;40:290-296.
37. Cleare AJ, Messa C, Rabiner EA, Grasby PM. Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635. Biol Psychiatry 2005;57:239-246.
38. Castell LM, Yamamoto T, Phoenix J, Newsholme EA. The role of tryptophan in fatigue in different conditions of stress. Adv Exp Med Biol 1999;467:697-704.
39. Georgiades E, Behan WM, Kilduff LP, et al. Chronic fatigue syndrome: New evidence for a central fatigue disorder. Clin Sci (Lond) 2003;105:213-218.
40. Peckerman A, LaManca JJ, Qureishi B, et al. Baroreceptor reflex and integrative stress responses in chronic fatigue syndrome. Psychosom Med 2003;65:889-895.
41. Lieberman HR, Corkin S, Spring BJ, Wurtman RJ, Growdon JH. The effects of dietary neurotransmitter precursors on human behavior. Am J Clin Nutr 1985;42:366-370.
42. Lieberman HR, Corkin S, Spring BJ, et al. The effects of tryptophan and tyrosine on human mood and performance. Psychopharmacol Bull 1984;20:595-598.
43. Cunliffe A, Obeid OA, Powell-Tuck J. A placebo-controlled investigation of the effects of tryptophan or placebo on subjective and objective measures of fatigue. Eur J Clin Nutr 1998;52:425-430.
44. Emiliano AB, Fudge JL. From galactorrhea to osteopenia: Rethinking serotonin-prolactin interactions. Neuropsycho-pharmacology 2004;29:833-846.
45. Moroni F. Tryptophan metabolism and brain function: Focus on kynurenine and other indole metabolites. Eur J Pharmacol 1999;375:87-100.
46. Kostoglou-Athanassiou I, Treacher DF, Wheeler MJ, Forsling ML. Melatonin administration and pituitary hormone secretion. Clin Endocrinol (Oxf) 1998;48:31-37. (Pubitemid 28122430)